Royal Bank of Canada cut shares of Udg Healthcare (LON:UDG) to a sector performer rating in a report published on Monday morning, Digital Look reports. They currently have GBX 800 ($10.45) price objective on the stock, down from their previous price objective of GBX 830 ($10.85).
Several other equities analysts have also recently commented on UDG. Numis Securities raised shares of Udg Healthcare to a hold rating in a research report on Thursday, May 16th. Peel Hunt reiterated a buy rating on shares of Udg Healthcare in a research note on Wednesday, August 7th. Finally, Liberum Capital reiterated a buy rating on shares of Udg Healthcare in a research note on Wednesday, August 7th. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Udg Healthcare has a consensus rating of Hold and a consensus price target of GBX 799.86 ($10.45).
Udg Healthcare stock opened at GBX 784 ($10.24) on Monday. The company has a debt-to-equity ratio of 26.96, a quick ratio of 1.85 and a current ratio of 1.94. Udg Healthcare has a fifty-two week low of GBX 545 ($7.12) and a fifty-two week high of GBX 819 ($10.70). The business’s 50-day simple moving average is GBX 781.52 and its two-hundred day simple moving average is GBX 676.85. The company has a market cap of $1.95 billion and a PE ratio of 76.12.
UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services.
Recommended Story: Do stock splits help investors?
Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.